The latest acquisition continues Triton’s strategy to add-value to the company through the addition of high-quality medicines and strengthen the company’s offering in Cardiovascular healthcare.

Read the full article here

https://realdeals.eu.com/article/tritons-atnahs-acquires-portfolio-of-cardiovascular-medicines